Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).

@article{Lattanzi2011MeasuresOD,
  title={Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).},
  author={Bianca Lattanzi and Alessandro Consolaro and Nicoletta Solari and Nicolino Ruperto and Alberto Martini and Angelo Ravelli},
  journal={Arthritis care & research},
  year={2011},
  volume={63 Suppl 11},
  pages={S112-7}
}
Although the presentation, clinical symptoms, and laboratory findings of pediatric systemic lupus erythematosus (SLE) are similar to those that are seen in adults, children and adolescents with SLE differ from adults in terms of the frequency and severity of disease activity and damage features as well as in the treatment approaches used by their attending physicians. Furthermore, assessment of pediatric patients with SLE should take into account the disease and physical/mental age–related… CONTINUE READING